Physicochemical Properties
| Molecular Formula | C24H16CL2FNO4 |
| Molecular Weight | 472.29 |
| Exact Mass | 471.044 |
| CAS # | 2615911-12-9 |
| PubChem CID | 162640914 |
| Appearance | Light yellow to yellow solid powder |
| LogP | 5.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Heavy Atom Count | 32 |
| Complexity | 752 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | O1C2=CC=C3C(=O)C(O)=C(C4=CC=C(Cl)C(Cl)=C4)OC3=C2CN(CC2=CC=CC(F)=C2)C1 |
| InChi Key | YHKREPOFPNSZAL-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C24H16Cl2FNO4/c25-18-6-4-14(9-19(18)26)23-22(30)21(29)16-5-7-20-17(24(16)32-23)11-28(12-31-20)10-13-2-1-3-15(27)8-13/h1-9,30H,10-12H2 |
| Chemical Name | 2-(3,4-dichlorophenyl)-9-[(3-fluorophenyl)methyl]-3-hydroxy-8,10-dihydropyrano[2,3-f][1,3]benzoxazin-4-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. Design, Synthesis, and Biological Evaluation of Icaritin Derivatives as Novel Putative DEPTOR Inhibitors for Multiple Myeloma Treatment. J Med Chem. 2021 Oct 28;64(20):14942-14954. |
Solubility Data
| Solubility (In Vitro) | DMSO: 4 mg/mL (8.47 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 0.4 mg/mL (0.85 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 4.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1173 mL | 10.5867 mL | 21.1734 mL | |
| 5 mM | 0.4235 mL | 2.1173 mL | 4.2347 mL | |
| 10 mM | 0.2117 mL | 1.0587 mL | 2.1173 mL |